AXM Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2017	FY 2005
Period Ending	Dec '17 Dec 31, 2017	Dec '05 Dec 31, 2005
Net Income	8.18	-
Depreciation & Amortization	1.16	-
Other Operating Activities	4.03	-
Change in Accounts Receivable	0.71	-
Change in Inventory	-5.74	-
Change in Accounts Payable	30.44	-
Change in Income Taxes	-4.03	-
Operating Cash Flow	34.76	-
Capital Expenditures	-21.62	-
Other Investing Activities	-1.06	-
Investing Cash Flow	-22.69	-
Long-Term Debt Repaid	-13	-
Net Debt Issued (Repaid)	-13	-
Other Financing Activities	0.21	-
Financing Cash Flow	-12.79	-
Foreign Exchange Rate Adjustments	-0.6	-
Net Cash Flow	-1.32	-
Free Cash Flow	13.14	-
Free Cash Flow Margin	11.62%	-
Free Cash Flow Per Share	0.00	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.